Molecular Pathway Identified Linking Stress Kinase to Persistent Lung Scarring in Aging and Pulmonary Fibrosis

Researchers find that inhibiting p38 MAPK can block the epigenetic activation of genes that cause lung scarring, offering hope for new IPF treatments.

By: AXL Media

Published: Mar 10, 2026, 11:59 AM EDT

Source: The information in this article was sourced from Impact Journals LLC

Decoding the Epigenetic Drivers of Chronic Lung Scarring

A new study has shed light on the molecular machinery that causes the lungs to lose their elasticity and develop life-threatening scars as they age. Researchers from Eastern Virginia Medical School have identified a specific protein, p38 MAPK, as a primary driver behind the persistent activation of profibrotic genes in lung fibroblasts. This discovery is particularly significant for understanding Idiopathic Pulmonary Fibrosis (IPF), a disease characterized by the irreversible stiffening of lung tissue that often accelerates in older populations.

The Role of p38 MAPK in Sustained Cellular Stress

The research team, led by Shan Zhu and Yan Y. Sanders, focused on how lung cells respond to TGF-beta1, a well-known signaling protein that triggers tissue repair. In young cells, this response is typically controlled and temporary. However, the study found that in senescent or "near-senescent" lung cells, the p38 MAPK response to this trigger is delayed but significantly sustained. This prolonged activity creates a continuous signal for the cell to produce collagen and other scarring proteins, even when the initial repair stimulus should have subsided.

Epigenetic Modifications and the H4K16ac Marker

The most groundbreaking aspect of the research involves the epigenetic mechanism linking p38 signaling to DNA activation. By using advanced ChIP assays, the team observed that p38 MAPK activity leads to an enrichment of H4K16 acetylation (H4K16ac) at the promoters of fibrotic genes such as alpha-SMA and Col3A1. Essentially, the kinase acts as a key that unlocks the chromatin, keeping the genes responsible for lung scarring in a permanent "on" position through chemical modifications to the DNA packaging.